Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Admixture facilitates genetic adaptations to high altitude in Tibet.
Calcium channel blocking agents in bronchial hyperreactivity.
Dexamethasone decreases xenograft response to Paclitaxel through inhibition of tumor cell apoptosis.
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.
Vasospasm in monkeys resolves because of loss of and encasement of subarachnoid blood clot.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer. N Engl J Med. 2015 Oct 22; 373(17):1627-39.
View in:
PubMed
subject areas
Aged
Antibodies, Monoclonal
Antineoplastic Agents
B7-H1 Antigen
Carcinoma, Non-Small-Cell Lung
Female
Humans
Lung Neoplasms
Male
Middle Aged
Survival Analysis
Taxoids
authors with profiles
Everett E. Vokes